Kano Therapeutics
Scott Hamilton is a seasoned professional in the bioprocess and manufacturing sectors, currently serving as the Director of CMC at Kano Therapeutics since February 2024. Prior experience includes a role as the Director of Process Development at Endolytix, where responsibilities involved strategic fermentation processes for protein production and optimizing team efficiency. Additionally, Scott held the position of Associate Director of Manufacturing at Synlogic, Inc., overseeing cGMP manufacturing operations and ensuring compliance with regulatory standards. With a solid foundation in bioprocess engineering, Scott has worked in various roles, including Senior Lead Process Engineer and Bioprocess Engineer, across multiple companies such as Inari Agriculture and GreenLight Biosciences, contributing to significant advancements in biomanufacturing processes. Scott's academic credentials include a Master of Science in Marine Biology from the University of Maine and a Bachelor of Arts in Biological Sciences and Environmental Science from Goucher College.
This person is not in any teams
Kano Therapeutics
Kano Therapeutics is a founder-led biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them, empowering scientists, labs, and companies with the building blocks they need to cross the chasm to cures.